Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW — Cannabis Drinks: What You Should Know

As cannabis is legalized for recreational use in more states across the country, the popularity of cannabis products is increasing, especially cannabis drinks.

What are cannabis drinks?

These are beverages that have cannabis infused into them. Cannabis drinks and hemp-infused beverages don’t always contain alcohol, seeing as most are marketed as alternatives to alcohol. Some do contain cannabinoids such as CBN, CBG and CBD, while others contain THC, which is a psychoactive ingredient.

There is an option for both CBD and THC-infused beverages in some jurisdictions.

So, what’s the difference between CBD drinks and hemp drinks?

Cannabis sativa is an umbrella term used to refer to both marijuana and hemp plants. So when we talk about the cannabis industry, we’re referring to more than just weed. Cannabinoids such as hemp oil, Delta-8 and CBD are also included when we refer to this particular industry.

It should be noted that there are different markets within this industry. Additionally, most CBD- and THC-infused drinks aren’t classified as edibles.

The hemp market is involved in the sale of all products derived from hemp. The difference between CBD and hemp is mainly found in how the product is sourced. Hemp plants produce a lot of cannabinoids, including CBD. Hemp products are made with or from hemp oil. These products are usually sourced from the plant’s seeds while CBD products are sourced from the plant’s leaves and stem. This is why CBD products don’t contain hemp oil.

With regard to drinks, hemp beverages are infused with broad-spectrum hemp oil extracted from the hemp plant. These beverages contain small CBD amounts but high concentrations of terpenes and other cannabinoids.

Research has found that hemp soothes general inflammation, promotes heart health, lowers blood pressure and has a positive impact on mood.

On the other hand, CBD drinks are infused with CBD isolate, which means they lack THC. This explains why CBD-infused drinks are calming and relaxing. Although research is limited, CBD has demonstrated strong potential for effectively managing chronic pain, insomnia and anxiety.

What about THC drinks?

THC, or tetrahydrocannabinol, is the chemical responsible for most of the cannabis plant’s psychological effects. This means that THC beverages are infused with the cannabis plant’s main psychoactive compound. These beverages are better enjoyed when sipped on slowly rather than consumed quickly.

Depending on the potency of the THC drink, users may experience a sense of relief and euphoria or get wasted, especially if they drink too much of it, too fast.

Companies such as BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) have advanced the science of making cannabis beverages to such an extent that the segment is light years ahead of where it started.

NOTE TO INVESTORS: The latest news and updates relating to BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) are available in the company’s newsroom at http://cnw.fm/BVNNF

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Researchers Identify Clues Explaining Why Low-Dose Full-Spectrum CBD Products Can Have Powerful Effects

The past five years or so have seen cannabinoids, led by THC and CBD, become immensely popular. While THC is responsible for marijuana’s intoxicating effects, CBD (cannabidiol) has shown a diverse range of possible medicinal properties. Most of the research is still in the preliminary stages; however, cannabidiol has been found to be effective against various symptoms ranging from anxiety and insomnia to chronic pain and epilepsy.

As CBD products became more accessible, some users noticed that full-spectrum CBD products that contain other minor cannabinoids, other than except for THC, and terpenes seemed to be more effective than CBD isolate products. In the wake of these claims, experts came up with a theory called the “entourage effect,” which states that the sum of all the chemical compounds in cannabis is better than a single cannabinoid taken on its own.

A new study by University of Sweden pharmacologists has uncovered clues on how this phenomenon, which they call the “pharmacokinetic entourage mechanism,” works, especially in regards to low-dose CBD products. According to the lead author of the study Dr. Lyndsey Anderson, cannabidiolic acid (“CBDA”) may have a greater role in the effects of low-dose CBD products.

CBDA has been found to reduce anxiety and seizures in preclinical trials, and it may very well be responsible for creating these effects when low-dose CBD products are consumed. CBDA, which is the precursor of CBD, turns into cannabidiol after the decarboxylation process. The study found that when users consume a full-spectrum CBD product, cannabinoids interact and produce cannabidiolic acid in much higher concentrations.

Compared to when CBDA was administered on its own, the full-spectrum CBD product delivered 14 times more CBDA in the bloodstream in animal trials using mice, says associate professor Jonathan Arnold with the Lambert Initiative for Cannabinoid Therapeutics. By interacting at specific transport proteins in the gut, Arnold says the range of cannabinoids in full-spectrum hemp extracts helped increase the rate of absorption of CBDA into the bloodstream. There has been little scientific proof to support the entourage effect since the theory first gained prominence, but this study has provided evidence showing that cannabinoids can interact and alter, among other things, their levels in the bloodstream, which will, in turn, affect how a CBD product will affect the user.

In this case, cannabinoids increase the levels as well as the rate of absorption of CBDA, which is known to reduce anxiety and seizures. Consequently, full-spectrum, low-dose CBD products appear to have the same anti-anxiety and anticonvulsant effects as cannabidiolic acid. The researchers, who published their study in Scientific Reports, will continue studying the entourage effect and learn how they can leverage its pharmaceutical potential.

If these findings are anything to go by, cannabis industry players such as Hero Technologies Inc. (OTC: HENC) are offering cannabis users a great service by manufacturing high-quality CBD and other cannabis products whose ingredients remain intact.

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Naturo Group Awarded Contract with BC Wildfire Service

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) today announced that its wholly owned subsidiary, Naturo Group, has been selected by the British Columbia Ministry of Forests, Lands, Natural Resource Operations and Rural Development, and has commenced manufacturing and delivery of a Special Limited Edition TRACE-branded white-label water for the Ministry’s Wildfire Services Division. “We’re pleased that we’ve been awarded the contract with BC Wildfire Service,” said Melise Panetta, president of BevCanna. “We are proud to be providing the firefighters with a special edition of our TRACE-branded natural 7.7ph alkaline spring water, sourced directly from our proprietary B.C. Interior aquifer – the very land and forest that they work so hard to keep safe. We think that it’s very fitting that these heroes will be kept hydrated with B.C.’s own TRACE-branded water. We’ve already begun production and delivery to the firefighters.”

To view the full press release, visit https://cnw.fm/VnT6p

About BevCanna Enterprises Inc.

BevCanna Enterprises is a diversified health and wellness beverage and natural products company. BevCanna develops and manufactures a range of plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients. With decades of experience creating, manufacturing and distributing iconic brands that resonate with consumers on a global scale, the team demonstrates an expertise unmatched in the nutraceutical and cannabis-infused beverage categories. Based in British Columbia, BevCanna owns a pristine alkaline spring water aquifer and a world-class, 40,000-square-foot, HACCP-certified manufacturing facility, with a bottling capacity of up to 210M bottles annually. BevCanna’s extensive distribution network includes more than 3,000 points of retail distribution through its market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network, and a partnership with number-one U.S. cannabis beverage company Keef Brands. For more information about the company, visit www.BevCanna.com.

NOTE TO INVESTORS: The latest news and updates relating to BVNNF are available in the company’s newsroom at http://cnw.fm/BVNNF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Announces Plans to Acquire Le Pragma LLC

Golden Triangle Ventures (OTC: GTVH) (“GTV”), a multifaceted consulting company pursuing ventures across health, entertainment and technology industries, today announced its entry into a letter of intent (“LOI”) to acquire Le Pragma LLC. Comprised of a full retail line of all-natural, high-end health, wellness and beauty products, Le Pragma has a strategic vision of becoming the CBD line of the future. Le Pragma leverages cutting-edge formulations and dedication to a precise science to deliver optimal wellness throughout its quality product line. “Our team has worked very hard to formalize a strong plan to push sales, strengthen the products involved and launch this business directly into the international markets after we formally acquire Le Pragma,” said Steffan Dalsgaard, CEO of Golden Triangle Ventures. “We look forward to officially bringing this business in under the GTV umbrella, and we are all confident that we have a stellar product with a direct plan to generate profits for our company.”

To view the full press release, visit https://cnw.fm/1mJED

About Golden Triangle Ventures Inc.

Golden Triangle Ventures is a multifaceted consulting company pursuing ventures in the health, entertainment and technology industries, with many additional projects being developed that provide synergistic values to these divisions. The company aims to purchase, acquire and/or joint venture with established entities that management can help assist and develop into unique opportunities. Additionally, GTVH provides a professional corporate representation service to different companies in these sectors while consulting on a variety of business development objectives. The goods and services represented are driven by innovators who have passion and commitment to these marketplaces. The company plans to utilize relationships and create a platform for new and existing businesses to strengthen their products and/or services. The three points of the Golden Triangle exclusively represent these three sectors in which the company aims to do business. For more information, visit the company’s website at www.GoldenTriangleInc.com.

NOTE TO INVESTORS: The latest news and updates relating to GTVH are available in the company’s newsroom at https://cnw.fm/GTVH

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reaches Milestone in Human Clinical Study, Notes Growing Availability of DehydraTECH-Enabled Products

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has reached a significant point in its second human clinical study of 2021: HYPER-H21-2. The company announced that dosing has been completed in the study, which was comprised of 16 human volunteers who were pre- or mildly hypertensive; each participant received three separate doses of 150 mg each of DehydraTECH(TM) 2.0-enabled CBD versus a placebo. The study also included 24-hour continuous monitoring of blood pressure and heart rate, as well as evaluations of central arterial stiffness, physical activity and sleep quality. This key information will be assessed to evaluate the human response to DehydraTECH 2.0-enabled CBD. The company anticipates beginning a third human clinical study, HYPER-H21-3, following analysis of results from the first and second studies. In addition, Lexaria announced the expansion of its intellectual property portfolio with the allowance of its second patent in Japan. The patent is the 21st patent the company has been granted. Lexaria also noted that more than 7,000 stores across the country sell products that use its exclusive DehydraTECH technology. Some of those products include Cannadips, the original tobacco-free and nicotine-free CBD pouch; a growing number of New World CBD SKUs; and next-generation CHYLOSOMA(TM) formulations of CBD, CBG and CBN topical skin offerings. “Lexaria’s technology is enabling increased market share and sales growth for our continually growing list of corporate clients,” said Lexaria CEO Chris Bunka. “We are delighted to help these innovators of today and leaders of tomorrow offer their clients superior performance and experiences that competitors simply cannot match, and we are highly anticipatory of additional growth to come.”

To view the full press releases, visit https://cnw.fm/mM3a5 and https://cnw.fm/IwTRR

About Lexaria Bioscience Corp.

Lexaria Bioscience’s proprietary drug-delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules, thereby lowering overall dosing. The company’s technology can be applied to many different ingestible product formats including foods, beverages, oral suspensions, tablets and capsules. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption of cannabinoids and nicotine by up to 5 to 10 times, reduce time of onset from one to two hours to minutes, and mask unwanted tastes; the technology is planned to be further evaluated for orally administered bioactive molecules including anti-viral drugs, vitamins, nonsteroidal anti-inflammatory drugs (NSAIDs) and more. Lexaria has licensed DehydraTECH to multiple companies including a world-leading tobacco producer for the development of smokeless, oral-based nicotine products and for use in industries that produce cannabinoid beverages, edibles and oral products. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 21 patents granted and more than 50 patents pending worldwide. For more information about the company, please visit http://www.LexariaBioScience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — California Launches Cannabis Agency to Ease Industry Regulation

America’s state legal cannabis sector has seen major growth in the past few years as more states have legalized cannabis. California, which legalized recreational marijuana five years ago, has since sold $4.4 billion worth of cannabis, making its cannabis sector one of, if not the most,  successful cannabis markets in America. Now in a move that is meant to simplify how California regulates its massive and swiftly growing cannabis space, Governor Gavin Newsom has signed a law creating a single agency to regulate cannabis.

The policy, which Newsom first proposed in January 2020, will consolidate licensing authority from the three departments responsible for regulating California’s cannabis space: the Manufactured Cannabis Safety Branch under the Department of Health, the Bureau of Cannabis Control under the Department of Consumer Affairs, and CalCannabis under the Department of Food and Agriculture. Under the new law, a single Department of Cannabis Control will now handle the licensing, enforcement and environmental oversight duties that these three department were previously tasked with.

According to the budget summary for Newsom’s 2020–2021 budget plan where he introduced the new policy, a single department for cannabis regulation that would “centralize and align critical regulatory functions.” Additionally, it would create a single point of contact for individuals within the cannabis space as well as local governments rather than three different departments. The Department of Cannabis Control (“DCC”), which is under the Business, Consumer Services and Housing Agency, will also be in charge of California’s track and trace system, which follows cannabis and cannabis products through the state’s legal supply chain.

Lindsey Robison, executive director of the California Cannabis Industry Association, which represents more than 400 licensed cannabis enterprises, has applauded the new law. She says navigating three agencies with different protocols and processes has often been a bone of contention for many cannabis businesses, and having all their functions housed under a single agency will help with communication, transparency and, hopefully, process times for applications.

According to the acting deputy director of the DCC Christina Dempsey, Newsom’s administration wants to make the legal market more attractive than the illicit market. Despite having one of the largest cannabis industries in the country, California is still plagued by the cannabis black market. Not only do illegal cannabis grows deprive the state of tax revenue, but they also steal tons of water and electricity and are responsible for violence, forced labor and the destruction of the ecosystem.

Employees of the three agencies will continue using their offices until further notice. In addition, because existing licenses will be transferred to the DCC, cannabis businesses will not need to apply for new licenses until existing licenses expire. Furthermore, law enforcement and local government will continue working with their existing contacts, and policies for grant funding for researchers will remain the same. The Department of Cannabis Control will reside at 2920 Kilgore Road in Rancho Cordova.

It remains to be seen how the new agency will make it easier for cannabis companies in California, such as Grapefruit USA Inc. (OTCQB: GPFT), to interact with regulators and comply with all the existing laws governing the industry.

NOTE TO INVESTORS: The latest news and updates relating to Grapefruit USA Inc. (OTCQB: GPFT) are available in the company’s newsroom at http://cnw.fm/GPFT

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Study Finds That Cannabis Legalization Boosts Home Property Values

Research conducted by Clever Real Estate has found that the presence of marijuana dispensaries and the legalization of marijuana helps grow home property values. The real estate service company used data from the U.S. Census and Zillow, as well as other sources for the study, which discovered that between 2017 and 2019, the value of homes increased by more than $6,000 in states where cannabis is legal in some form. This is in comparison to home values in states that haven’t legalized cannabis.

The increase in value may be driven by the tax revenues generated from the regulation and legalization of marijuana. The company found that this revenue was commonly invested into things such as infrastructure and public services, which significantly increased property value. According to the research, home values grew by nearly $500 for every $1 million in additional tax revenue generated from the sale of cannabis.

For instance, the state of Illinois sold nearly $670 million in marijuana and generated more than $200 million in tax revenue in 2020. This revenue was allocated to different causes, including the support of organizations that work to reduce street violence. Decreasing violence in communities is a good way to drive up property value. The study also discovered that states that legalized adult-use marijuana saw the highest increases in property value.

In its report, the company stated that in comparison with states where cannabis is limited to medicinal use or is still illegal, property values in states where recreational cannabis is legal rose by roughly $17,000 in the period between April 2017 and April 2021. It added that in states where legal sales are yet to begin but legalization has been enacted, property values are expected to rise by an average of $61,000.

The company notes that the presence of marijuana dispensaries seems to correspond to the increase in home property value, with findings showing that home values grew by more than $22,000 more in regions with recreational dispensaries. An analysis conducted by economists from the University of Oklahoma in 2020 also discovered that states that legalized cannabis saw increments in housing prices, with retail outlets opening for business driving this up further.

The researchers noted that this showed that the existence of dispensaries, coupled with the benefits of additional tax revenue drove the increments in price, arguing that the cannabis dispensaries were viewed as commercial amenities that the general public deemed to be valuable and/or important.

Furthermore, companies that sell cannabinoid products, such as The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER), employ lots of people — and that alone creates more demand for homes, therefore hiking property values as those employees seek to buy houses in the vicinity.

NOTE TO INVESTORS: The latest news and updates relating to The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) are available in the company’s newsroom at http://cnw.fm/WTER

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Announces Q1 2021 Financial Results

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, today announced its 2021 first quarter financial results and subsequent events. “This was another great quarter for the company as we continued to see strong traction for our brands,” said Brad Rogers, RWB’s chairman & CEO. “We are building on that momentum and working towards finalizing our revised asset purchase of our Michigan investee to bring their revenue, as well as adjusted sales into IFRS revenue format before the end of this current quarter. Once complete, and the expansion of our Florida operations come on stream, we can finally report in our quarterly results the strength of what we have built and accomplished thus far.”

To view the full press release, visit https://cnw.fm/egQMZ

About Red White & Bloom Brands Inc.

The company is positioning itself to be one of the top three multistate cannabis operators active in the U.S. legal cannabis and hemp sector. RWB is predominantly focusing its investments on the major U.S. markets, including Michigan, Illinois, Massachusetts, Arizona and California with respect to cannabis, and the U.S. and internationally for hemp-based CBD products. For more information about the company, visit www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://cnw.fm/RWBYF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CBDNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) Creating Brand Loyalty by ‘Doing It Right’

HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leader in the health and wellness cannabidiol (“CBD”) industry, has made compliance with regulatory standards for hemp-derived products worldwide one of its main priorities. This has opened doors to outlets for its products while many other CBD companies have struggled. In a June 29 Hemp Barons podcast, HempFusion co-founder and CEO Jason Mitchell and host Joy Beckerman extensively discussed the regulatory journey CBD dietary supplements, as well as OTC cosmetic topicals, have taken under guidance from the U.S. federal government. A recent article quotes Mitchel as saying, “The fact is, it’s really fun to do it right, because it’s challenging. And then when you see the consumer response that they get the result they want, and that you did it correctly . . . they’re going to have a tremendous amount of trust in you and have longevity in their support of your brand . . . and so that’s why we did it. We create this brand loyalty by virtue of doing it right.”

To view the full article, visit https://cnw.fm/x3zgH

About HempFusion Wellness Inc.

HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research, and HF Labs, to approximately 4,000 retailers across all 50 U.S. states and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 46 SKUs, including tinctures, proprietary FDA Drug-listed over-the-counter (“OTC”) topicals, doctor/practitioner lines, and more. With a strong focus on R&D, HempFusion has an additional 30 products under development. HempFusion is a board member of the U.S. Hemp Roundtable, and HempFusion’s wholly owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex(TM) and are available in-store or by visiting HempFusion online at www.Hempfusion.com or www.Probulin.com.

NOTE TO INVESTORS: The latest news and updates relating to CBDHF are available in the company’s newsroom at https://cnw.fm/CBDHF

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Is Frontrunner in Search for Elusive Prize

Pac Roots (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) is well equipped to pursue – and achieve – the quest for consistency and customization that offers value for money to recreational cannabis users. “The company’s unique partnership with Phenome One, recognized as one of Canada’s largest live genetic libraries, allows Pac Roots to focus on selective breeding and preservation,” reads a recent article. “That key partnership, which enables Pac Roots to optimize the genetic makeup of its cannabis plants as well as develop unique strains featuring a variety of beneficial characteristics, established the company as a frontrunner in the search for what the New York Times called an elusive prize: ‘a predictable, reliable product.’ With Phenome One in its corner, along with existing infrastructure, equipment and access to land as well as aligned brands, Pac Roots is ideally positioned to preserve the excellence of its elite strains while also introducing the highest quality strains.”

To view the full article, visit https://cnw.fm/zVJ9E

About Pac Roots Cannabis Corp.

Pac Roots is the future of genetics. By focusing on elite cannabis genetic development, the company maximizes the quality of its products by keeping yields and profit margins high. Pac Roots subsidizes costs with several strategic partners: Phenome One, one of the largest live genetic libraries in Canada composed of over 350+ live cultivars, as well as its JV partnership with Rock Creek Farms and Speakeasy Cannabis Club, leveraging existing infrastructure, equipment and access to land on a 100-acre hemp project. This combination has the company positioned to be cash-flow positive within their first year of trading. For more information about the company, visit www.PacRoots.ca.

NOTE TO INVESTORS: The latest news and updates relating to PACR are available in the company’s newsroom at http://cnw.fm/PACR

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.